Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Corebridge Financial
CRBG
$15B
| $16.7M | ﹤0.01% |
1,040,048
+52,357
| +5% | +$1.03M |
|
1927
PureCycle Technologies
PCT
$1.45B
| $16.6M | ﹤0.01% |
2,376,234
+95,258
| +4% | +$664K |
|
1928
Marcus & Millichap
MMI
$1.19B
| $16.6M | ﹤0.01% |
517,311
+17,625
| +4% | +$612K |
|
|
DCH
1929
Dauch Corp
DCH
$1.51B
| $16.6M | ﹤0.01% |
2,126,858
+74,833
| +4% | +$642K |
|
|
DCPH
1930
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $16.5M | ﹤0.01% |
1,066,104
+154,710
| +17% | +$2.58M |
|
1931
Mercury Insurance
MCY
$6.07B
| $16.4M | ﹤0.01% |
516,855
+17,259
| +3% | +$589K |
|
1932
AbCellera Biologics
ABCL
$2.12B
| $16.4M | ﹤0.01% |
2,175,548
+108,035
| +5% | +$981K |
|
1933
Upstart Holdings
UPST
$3.03B
| $16.4M | ﹤0.01% |
1,029,182
+42,940
| +4% | +$722K |
|
|
PENG
1934
Penguin Solutions Inc
PENG
$2.99B
| $16.3M | ﹤0.01% |
946,018
+31,570
| +3% | +$527K |
|
1935
Immunovant
IMVT
$8.25B
| $16.3M | ﹤0.01% |
1,048,718
+45,123
| +4% | +$783K |
|
1936
Biohaven
BHVN
$2.21B
| $16.3M | ﹤0.01% |
1,190,494
+69,890
| +6% | +$1.11M |
|
1937
Hawkins
HWKN
$2.71B
| $16.2M | ﹤0.01% |
371,088
+16,076
| +5% | +$650K |
|
1938
Hayward Holdings
HAYW
$3.36B
| $16.2M | ﹤0.01% |
1,380,637
+167,444
| +14% | +$2.05M |
|
1939
Origin Bancorp
OBK
$1.66B
| $16.2M | ﹤0.01% |
503,174
+17,998
| +4% | +$661K |
|
|
ARR
1940
Armour Residential REIT
ARR
$2.36B
| $16.1M | ﹤0.01% |
613,651
+95,342
| +18% | +$2.7M |
|
1941
Icon
ICLR
$12.7B
| $16M | ﹤0.01% |
75,095
+1,223
| +2% | +$272K |
|
1942
NetEase
NTES
$84.7B
| $16M | ﹤0.01% |
180,839
+3,657
| +2% | +$315K |
|
1943
Benchmark Electronics
BHE
$2.96B
| $16M | ﹤0.01% |
676,124
+30,840
| +5% | +$781K |
|
1944
Tootsie Roll Industries
TR
$2.98B
| $16M | ﹤0.01% |
389,717
+7,848
| +2% | +$313K |
|
1945
Enanta Pharmaceuticals
ENTA
$400M
| $16M | ﹤0.01% |
395,076
+16,135
| +4% | +$770K |
|
|
INN
1946
Summit Hotel Properties
INN
$700M
| $16M | ﹤0.01% |
2,279,339
+89,274
| +4% | +$677K |
|
|
PWSC
1947
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $16M | ﹤0.01% |
804,881
+99,329
| +14% | +$2.17M |
|
1948
IonQ
IONQ
$16.6B
| $15.9M | ﹤0.01% |
2,591,029
+129,350
| +5% | +$605K |
|
|
CSII
1949
DELISTED
Cardiovascular Systems, Inc.
CSII
| $15.9M | ﹤0.01% |
801,824
+42,058
| +6% | +$726K |
|
1950
Cimpress
CMPR
$2.31B
| $15.9M | ﹤0.01% |
362,885
+17,988
| +5% | +$614K |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.